Excessive HER‐2 expression activates signal transduction pathways that lead to uncontrolled cell proliferation and tumour progression, and overexpressing patients also have correspondingly lower survival rates and faster relapse.6, 7, 8. The gene discussed is ERBB2; the disease is neoplasm.